Abiopharma

Insmed Announces Positive Topline Results from Phase 2b Study of Treprostinil Palmitil Inhalation Powder (TPIP) as Once-Daily Therapy in Patients with Pulmonary Arterial Hypertension

Axsome Therapeutics Announces Availability ofSYMBRAVO® (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults

Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

MacroGenics and Sagard Healthcare Partners Enter intoZYNYZ® Royalty Purchase Agreement

Anixa Biosciences Breast Cancer Vaccine Receives National News Coverage

MIND Technology Announces Source Controller Order

Manitoba Harvest and Whole Foods Market Collaborate to Launch New Protein-Packed, Hemp+ Superfood Smoothie Boosters

Monte Rosa Therapeutics Announces FDA Clearance of IND Application for MRT-8102, a NEK7-Directed Molecular Glue Degrader for the Treatment of Multiple Inflammatory Diseases

ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics

Gyre Therapeutics Announces First Dosing in Phase 1 Trial of F230 for Pulmonary Arterial Hypertension in China